Remember, don’t get your hopes up on a stellar headline result on cashflow in the next quarterly report.
We need to look through the figures as the company shifted resources from contract work to ramp up initial preparations and production of FebriDx.
The June quarterly will provider a truer reflection of the progress the company has made all round.
Remember, don’t get your hopes up on a stellar headline result...
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.0¢ | $73.77K | 2.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200000 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 401146 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
3.3¢ |
Change
0.000 ( 0.60 %) |
||||
| Open | High | Low | Volume | ||
| 3.3¢ | 3.3¢ | 2.9¢ | 388732 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| LDX (ASX) Chart |